MarketCap
Facebook
X
Telegram
Oragenics EV/EBITDA Ratio | OGEN
Annual EV/EBITDA Ratio Oragenics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.0948 | -0.0943 | -0.0744 | 0.339 | 1.73 | -1.41 | -0.0304 | 0.812 | -0.803 | -3.11 | -2.83 | -3.14 | -5.65 | -3.87 | -2 | -137 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.73 | -137 K | -8.59 K |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aclaris Therapeutics
ACRS
|
-5.56 | $ 5.32 | 0.09 % | $ 652 M |  USA |
 |
ADC Therapeutics SA
ADCT
|
-3.2 | $ 1.05 | 0.46 % | $ 133 M |  Schweiz |
 |
Agenus
AGEN
|
-9.32 | $ 7.21 | 0.7 % | $ 214 M | USA |
 |
Фармсинтез
LIFE
|
-115 | - | - | - |  Russia |
 |
Akebia Therapeutics
AKBA
|
19.9 | $ 0.92 | 1.64 % | $ 237 M | USA |
 |
Alector
ALEC
|
-2.95 | $ 1.93 | 0.81 % | $ 199 M | USA |
 |
Amryt Pharma plc
AMYT
|
-75 | - | - | $ 621 M |  Britain |
 |
Aligos Therapeutics
ALGS
|
-0.949 | $ 5.05 | 1.2 % | $ 49.9 M | USA |
 |
Alkermes plc
ALKS
|
19.2 | $ 46.07 | 0.09 % | $ 7.59 B |  Irlanda |
 |
Allogene Therapeutics
ALLO
|
-3.13 | $ 1.69 | 0.58 % | $ 373 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
77.8 | $ 239.36 | 0.46 % | $ 31.4 B | USA |
 |
Altimmune
ALT
|
-3.49 | $ 3.24 | 0.31 % | $ 285 M | USA |
 |
ALX Oncology Holdings
ALXO
|
-1.27 | $ 1.76 | 0.53 % | $ 94.4 M | USA |
 |
Evelo Biosciences
EVLO
|
-0.456 | - | -14.46 % | $ 27.9 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
11.2 | $ 23.95 | 1.31 % | $ 1.12 B | USA |
 |
AnaptysBio
ANAB
|
26.4 | $ 54.31 | 0.15 % | $ 1.56 B | USA |
 |
Anika Therapeutics
ANIK
|
-27.5 | $ 20.84 | 0.24 % | $ 299 M | USA |
 |
ANI Pharmaceuticals
ANIP
|
9.16 | $ 73.59 | 2.05 % | $ 1.48 B | USA |
 |
Aptevo Therapeutics
APVO
|
0.398 | $ 1.72 | 0.58 % | $ 543 K | USA |
 |
Allakos
ALLK
|
-0.000271 | - | - | $ 28.6 M | USA |
 |
Aquestive Therapeutics
AQST
|
-7.66 | $ 4.82 | 0.21 % | $ 515 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
-0.593 | $ 15.6 | 0.25 % | $ 427 M |  Israel |
 |
Armata Pharmaceuticals
ARMP
|
-17.1 | $ 4.07 | 2.21 % | $ 147 M | USA |
 |
Assembly Biosciences
ASMB
|
-25.1 | $ 25.48 | 0.54 % | $ 286 M | USA |
 |
Actinium Pharmaceuticals
ATNM
|
-0.744 | $ 1.24 | 0.79 % | $ 38.7 M | USA |
 |
AbbVie
ABBV
|
24.9 | $ 262.51 | 0.01 % | $ 464 B | USA |
 |
Atara Biotherapeutics
ATRA
|
3.26 | $ 10.11 | 7.1 % | $ 127 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
37 | $ 16.96 | 5.15 % | $ 2.28 B |  Canada |
 |
Autolus Therapeutics plc
AUTL
|
-2.4 | $ 1.87 | 0.53 % | $ 498 M | Britain |
 |
Atea Pharmaceuticals
AVIR
|
-2.05 | $ 5.15 | 1.24 % | $ 420 M | USA |
 |
Axon Enterprise
AXON
|
1.57 K | $ 468.42 | 5.96 % | $ 36.6 B | USA |
 |
Axsome Therapeutics
AXSM
|
-53.8 | $ 211.97 | 3.87 % | $ 10.5 B | USA |
 |
Aytu BioScience
AYTU
|
6.2 | $ 1.97 | 0.5 % | $ 12.4 M | USA |
 |
BridgeBio Pharma
BBIO
|
-30 | $ 68.3 | 0.1 % | $ 13.1 B | USA |
 |
Bicycle Therapeutics plc
BCYC
|
0.703 | $ 3.64 | 0.68 % | $ 252 M | Britain |
 |
Black Diamond Therapeutics
BDTX
|
10.5 | $ 1.94 | 1.02 % | $ 110 M | USA |
 |
Beam Therapeutics
BEAM
|
-8.71 | $ 23.1 | 0.15 % | $ 2.28 B | USA |
 |
Biogen
BIIB
|
48.2 | $ 216.01 | 0.42 % | $ 31.6 B | USA |
 |
BioLineRx Ltd.
BLRX
|
-550 | $ 2.48 | 0.79 % | $ 6.11 B | Israel |
 |
AbCellera Biologics
ABCL
|
-6.16 | $ 11.67 | 2.28 % | $ 3.49 B | Canada |
 |
Benitec Biopharma
BNTC
|
-7.59 | $ 11.04 | 0.9 % | $ 514 M | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
-0.186 | - | - | $ 231 M | USA |
 |
Burford Capital Limited
BUR
|
24.7 | $ 3.87 | 0.8 % | $ 848 M | Britain |
 |
Clovis Oncology
CLVS
|
-19.7 | - | -7.23 % | $ 13 M | USA |
 |
Chimerix
CMRX
|
0.0697 | - | - | $ 756 M | USA |
 |
Concert Pharmaceuticals
CNCE
|
-0.207 | - | - | $ 401 M | USA |
 |
Cabaletta Bio
CABA
|
-1.49 | $ 2.49 | 0.39 % | $ 250 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
0.0726 | $ 2.24 | 0.89 % | $ 3.69 M | Israel |
 |
Catalyst Biosciences
CBIO
|
70.6 | $ 17.18 | 1.7 % | $ 1.53 B | USA |
 |
C4 Therapeutics
CCCC
|
-2.31 | $ 3.45 | 0.58 % | $ 286 M | USA |